OKYO Pharma Limited
Organization details
- Legal name
- OKYO Pharma Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- London
- Headquarters country
- Guernsey
- Ticker symbol
- OKYO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001849296
Board of directors
-
Bernard Denoyer · DirectorSince 2026
-
Gabriele M. Cerrone · Director · Executive ChairmanSince 2026
-
Gary S. Jacob · Director · CHIEF DEVELOPMENT OFFICERSince 2026
-
John P. Brancaccio · DirectorSince 2026
-
Robert John Dempsey · Director · CHIEF EXECUTIVE OFFICERSince 2026
-
Willy Jules Simon · DirectorSince 2026
Chief executives
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Tiziana Life Sciences Ltd. Same sectorvia Gabriele M. Cerrone
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 2026 | Patil Rajkumar V. Officer (Chief Scientific Officer) | Grant or award | +3,363 | $1.49 | $5,011 |
| Jul 22, 2026 | Robert John Dempsey Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant or award | +15,000 | $1.54 | $23,100 |
| Jul 21, 2026 | Mantelli Flavio Officer (CHIEF MEDICAL OFFICER) | Grant or award | +20,000 | $1.40 | $28,000 |
| Jul 21, 2026 | John P. Brancaccio Director | Grant or award | +5,000 | $1.48 | $7,400 |
| Jul 21, 2026 | Gabriele M. Cerrone Director, 10% owner | Grant or award | +22,500 | $1.45 | $32,625 |
| Jul 21, 2026 | Gary S. Jacob Director, Officer (CHIEF DEVELOPMENT OFFICER) | Grant or award | +3,500 | $1.40 | $4,900 |
| Jul 20, 2026 | Gabriele M. Cerrone Director, 10% owner | Grant or award | +25,000 | $1.40 | $35,000 |
| Jun 8, 2026 | Gabriele M. Cerrone Director, 10% owner | Grant or award | +300,000 | $1.72 | $516,000 |
| Oct 27, 2023 | Gabriele M. Cerrone Director, Officer (Executive Chairman) | Other | +70,071 | $1.50 | $105,107 |
| Oct 23, 2023 | Gabriele M. Cerrone Director, Officer (Executive Chairman) | Other | +499,468 | $1.50 | $749,202 |
| Sep 15, 2023 | John P. Brancaccio Director | Open-market purchase | +16,670 | $1.50 | $25,005 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about OKYO Pharma Limited
Who is the CEO of OKYO Pharma Limited?
Robert John Dempsey has been OKYO Pharma Limited's CHIEF EXECUTIVE OFFICER since March 2026.
How many directors are on OKYO Pharma Limited's board?
OKYO Pharma Limited's board has 6 directors: Bernard Denoyer, Gabriele M. Cerrone, Gary S. Jacob, John P. Brancaccio, Robert John Dempsey and Willy Jules Simon.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="okyo-pharma-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.